ArisGlobal announces CHEPLAPHARM selected LifeSphere platforms for pharmacovigilance
CHEPLAPHARM will use MultiVigilance, Business Intelligence, and Medical Information to support global safety operations and growth.
See the latest news and media coverage for ArisGlobal. We track all announcements, press releases, and industry mentions in real time, all in one place.
GenAI-powered life sciences software provider
arisglobal.comLast updated
In short: ArisGlobal was acquired by Dassault Systèmes for $1.8 billion, marking a major expansion of AI-driven intelligence for life sciences.
CHEPLAPHARM will use MultiVigilance, Business Intelligence, and Medical Information to support global safety operations and growth.
The acquisition will create a unified AI intelligence platform connecting molecule, patient, and real-world outcomes.
Regulatory affairs must take responsibility for product data to avoid inconsistencies that hinder AI and compliance with IDMP standards
New AI capabilities reduce manual data entry by up to 80% and accelerate triage by 70%.
French software maker Dassault Systèmes confirmed its full-year outlook on Thursday after reporting second-quarter revenue ...
ArisGlobal, a leading provider of pharmacovigilance software solutions, announces the general availability of SafetyMart, a comprehensive data mining and signal detection application which facilitates in-depth...
(MENAFN- EIN Presswire) EINPresswire/ -- The global Regulatory Information Management (RIM) Market is valued at USD 2.7 billion in 2026 and is projected to reach...
ArisGlobal launches XDI. ArisGlobal Massachusetts United States of America United Kingdom Germany Flori...
Track ArisGlobal and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to ArisGlobal and other trending companies.